HC Wainwright & Co. analyst Robert Burns downgrades Neoleukin Therapeutics (NASDAQ:NLTX) from Buy to Neutral.
Why The US Dollar, A Safe Haven For Worried Investors, Rebounded On Monday
The Invesco DB US Dollar Index Bullish Fund (NYSE: UUP) rebounded by 0.6% Monday morning after a difficult week last week.